AFG vs XP

AFG's Advanced Deterministic Scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. The stock trades below its growth-based intrinsic value of $279.66 but above the conservative Graham Number of $109.99, suggesting moderate undervaluation with structural risks. Profitability metrics like ROE (16.91%) and low Debt/Equity (0.43) are strong, but weak revenue growth (-0.80% YoY) and bearish insider activity weigh on momentum. Analysts recommend a 'buy' with a target price of $143.83, implying 12.5% upside, though recent price performance has been flat to negative in the short term.

XP Inc. exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and financial stability. The stock is significantly undervalued, trading at $19.63, which is slightly below its Graham Number ($20.01) and far below its growth-based intrinsic value ($55.17). While the technical trend is currently bearish and insider sentiment is lukewarm, the combination of a low P/E (10.12), high ROE (23.71%), and consistent earnings growth makes it a compelling value play. The company's ability to maintain high profit margins (29.09%) while growing revenue by 13.3% YoY suggests a strong competitive moat in the capital markets sector.